ChIP-seq Analysis to Explore DNA Replication Profile in Trifluridine-Treated Human Colorectal Cancer Cells in Vitro

Anticancer Research - Greece
doi 10.21873/anticanres.13502
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Anticancer Research USA Inc.

Related search

Replication Stress in Colorectal Cancer Stem Cells

Oncotarget
Oncology
2017English

Cost Effectiveness of Trifluridine/Tipiracil for Previously Treated Metastatic Colorectal Cancer in England and Wales

Clinical Colorectal Cancer
OncologyGastroenterology
2018English

DNA Polymerase Η Modulates Replication Fork Progression and DNA Damage Responses in Platinum-Treated Human Cells

Scientific Reports
Multidisciplinary
2013English

Real‐World Adherence in Patients With Metastatic Colorectal Cancer Treated With Trifluridine Plus Tipiracil or Regorafenib

Oncologist
Cancer ResearchMedicineOncology
2019English

Microarray and ChIP-seq Data Analysis Revealed Changes in P53-Mediated Transcriptional Regulation in Nutlin-3-Treated U2OS Cells

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2015English

DNA Methylotype Analysis in Colorectal Cancer

Oncology Reports
MedicineCancer ResearchOncology
1994English

Duration of Previous Treatment as a Prognostic Factor in Metastatic Colorectal Cancer Treated With Trifluridine/Tipiracil

Molecular and Clinical Oncology
Cancer ResearchOncology
2018English

Real-World Treatment Patterns Among Patients With Colorectal Cancer Treated With Trifluridine/Tipiracil and Regorafenib

Clinical Colorectal Cancer
OncologyGastroenterology
2018English

Human NOC3 Is Essential for DNA Replication Licensing in Human Cells

Cell Cycle
MedicineDevelopmental BiologyCell BiologyMolecular Biology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy